Tedavi Modalitesi Seçimi
Özet
Referanslar
Bellomo R, Baldwin I, Cole L, et al. Preliminary experience with high-volume hemofiltration in human septic shock. Kidney Int 1998;53(suppl 66):S182-S185.
Bellomo R, Baldwin I, Ronco C. Extracorporeal blood purification for sepsis and systemic inflammation: Its biologic rationale. Contrib Nephrol 2001;132:367-74.
Bellomo R, Boyce N. Continuous venovenous hemodiafiltration compared with conventional dialysis in critically ill patients with acute renal failure. ASAIO J 1993;39:M794-M797
Bellomo R, Kellum JA, Ronco C. 40 Years of Continuous Renal Replacement Therapy 2018;194:51-9
.Brunet S, Leblanc M, Geadah D, et al. Diffusive and convective solute clearance during continuous renal replacement therapy at various dialysate and ultrafiltration flow rates. Am J Kidney Dis 1999;34:486-92.
Kellum JA, Johnson JP, Kramer D, et al. Diffusive vs. convective therapy: Effects on mediators of inflammation in patients with severe systemic inflammatory response syndrome. Crit Care Med 1998;26:1995-2000.
Macias WL, Clark WR. Azotemia control by extracorporeal therapy in patients with acute renal failure. New Horiz 1995;3:688-93.
Ronco C, Brendolan A, Bellomo R. Current technology for continuous renal replacement therapies. In: Ronco C, Bellomo R, eds. Critical Care Nephrology 1998:1327-34.
Ronco C, Bellomo R, Homel P, et al. Effects of different doses in continuous veno-venous hemofiltration on outcomes of acute renal failure: A prospective randomized trial. Lancet 2000;355:26-30.
Ronco C, Bellomo R, Kellum JA, et al. Critical Care Nephrology. Third Edition. Philadephia:Elsevier, 2019:1005-9.
Tandukar S, Palevsky MP. Continuous Renal Replacement Therapy. CHEST 2019;155(3):626-38
Uchino S, Cole L, Morimatsu H, et al. Solute mass balance during isovolemic high volume hemofiltration. Intensive Care Med 2003;29:1541-6.
Uchino S, Fealy N, Baldwin I, et al. Pre-dilution vs. post-dilution during continuous veno-venous hemofiltration: Impact on filter life and azotemic control. Nephron Clin Pract 2003;94:c94-c98.
Vanholder R, De Smet R, Glorieux G, et al. Review on uremic toxins: Classification, concentration, and interindividual variability. Kidney Int 2003;63:1934-43.
Villa G, Neri M, Bellomo R, et al. Nomenclature for renal replacement therapy and blood purification techniques in critically ill patients: practical applications. Critical Care 2016;20(1):283.
Referanslar
Bellomo R, Baldwin I, Cole L, et al. Preliminary experience with high-volume hemofiltration in human septic shock. Kidney Int 1998;53(suppl 66):S182-S185.
Bellomo R, Baldwin I, Ronco C. Extracorporeal blood purification for sepsis and systemic inflammation: Its biologic rationale. Contrib Nephrol 2001;132:367-74.
Bellomo R, Boyce N. Continuous venovenous hemodiafiltration compared with conventional dialysis in critically ill patients with acute renal failure. ASAIO J 1993;39:M794-M797
Bellomo R, Kellum JA, Ronco C. 40 Years of Continuous Renal Replacement Therapy 2018;194:51-9
.Brunet S, Leblanc M, Geadah D, et al. Diffusive and convective solute clearance during continuous renal replacement therapy at various dialysate and ultrafiltration flow rates. Am J Kidney Dis 1999;34:486-92.
Kellum JA, Johnson JP, Kramer D, et al. Diffusive vs. convective therapy: Effects on mediators of inflammation in patients with severe systemic inflammatory response syndrome. Crit Care Med 1998;26:1995-2000.
Macias WL, Clark WR. Azotemia control by extracorporeal therapy in patients with acute renal failure. New Horiz 1995;3:688-93.
Ronco C, Brendolan A, Bellomo R. Current technology for continuous renal replacement therapies. In: Ronco C, Bellomo R, eds. Critical Care Nephrology 1998:1327-34.
Ronco C, Bellomo R, Homel P, et al. Effects of different doses in continuous veno-venous hemofiltration on outcomes of acute renal failure: A prospective randomized trial. Lancet 2000;355:26-30.
Ronco C, Bellomo R, Kellum JA, et al. Critical Care Nephrology. Third Edition. Philadephia:Elsevier, 2019:1005-9.
Tandukar S, Palevsky MP. Continuous Renal Replacement Therapy. CHEST 2019;155(3):626-38
Uchino S, Cole L, Morimatsu H, et al. Solute mass balance during isovolemic high volume hemofiltration. Intensive Care Med 2003;29:1541-6.
Uchino S, Fealy N, Baldwin I, et al. Pre-dilution vs. post-dilution during continuous veno-venous hemofiltration: Impact on filter life and azotemic control. Nephron Clin Pract 2003;94:c94-c98.
Vanholder R, De Smet R, Glorieux G, et al. Review on uremic toxins: Classification, concentration, and interindividual variability. Kidney Int 2003;63:1934-43.
Villa G, Neri M, Bellomo R, et al. Nomenclature for renal replacement therapy and blood purification techniques in critically ill patients: practical applications. Critical Care 2016;20(1):283.
